Literature DB >> 11316662

Decreased steroid responsiveness at night in nocturnal asthma. Is the macrophage responsible?

M Kraft1, Q Hamid, G P Chrousos, R J Martin, D Y Leung.   

Abstract

As peripheral blood mononuclear cells from patients with nocturnal asthma (NA) exhibit reduced steroid responsiveness at 4:00 A.M. as compared with 4:00 P.M., we hypothesized that NA is associated with increased nocturnal airway cell expression of GRbeta, an endogenous inhibitor of steroid action. Ten subjects with NA and seven subjects with nonnocturnal asthma (NNA) underwent bronchoscopy with bronchoalveolar lavage (BAL) at 4:00 P.M. and 4:00 A.M. BAL lymphocytes and macrophages were incubated with dexamethasone (DEX) at 10(-5) to 10(-8) M. DEX suppressed proliferation of BAL lymphocytes similarly at 4:00 P.M. and 4:00 A.M. in both groups. However, BAL macrophages from NA exhibited less suppression of IL-8 and TNF-alpha production by DEX at 4:00 A.M. as compared with 4:00 P.M. (p = 0.0001), whereas in the NNA group DEX suppressed IL-8 and TNF-alpha production equally at both time points. GRbeta expression was increased at night only in NA, primarily due to significantly increased expression by BAL macrophages (p = 0.008). IL-13 mRNA expression was increased at night, but only in the NA group and addition of neutralizing antibodies to IL-13 reduced GRbeta expression by BAL macrophages. We conclude that the airway macrophage may be the airway inflammatory cell driving the reduction in steroid responsiveness at night in NA, and this function is modulated by IL-13.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316662     DOI: 10.1164/ajrccm.163.5.2002058

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

Review 1.  Timing Matters: Circadian Rhythm in Sepsis, Obstructive Lung Disease, Obstructive Sleep Apnea, and Cancer.

Authors:  Kimberly K Truong; Michael T Lam; Michael A Grandner; Catherine S Sassoon; Atul Malhotra
Journal:  Ann Am Thorac Soc       Date:  2016-07

Review 2.  Biological Modulators in Eosinophilic Diseases.

Authors:  Panida Sriaroon; Mark Ballow
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 3.  Alpha and beta glucocorticoid receptors: relevance in airway diseases.

Authors:  Laura Pujols; Joaquim Mullol; César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

4.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma.

Authors:  Elena Goleva; Ling-Bo Li; P Taylor Eves; Matthew J Strand; Richard J Martin; Donald Y M Leung
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

5.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

Review 6.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

7.  T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease.

Authors:  Manminder Kaur; Lucy Jc Smyth; Paul Cadden; Seamus Grundy; David Ray; Jonathan Plumb; Dave Singh
Journal:  Respir Res       Date:  2012-03-14

Review 8.  Estrogen Signaling Modulates Allergic Inflammation and Contributes to Sex Differences in Asthma.

Authors:  Aleksander Keselman; Nicola Heller
Journal:  Front Immunol       Date:  2015-11-16       Impact factor: 7.561

9.  Effects of physical exercise training on nocturnal symptoms in asthma: Systematic review.

Authors:  Cristina de Oliveira Francisco; Swati Anil Bhatawadekar; Jessica Babineau; W Darlene Reid; Azadeh Yadollahi
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.